Page last updated: 2024-08-25

4-phenylbutylamine and Osteoarthritis, Knee

4-phenylbutylamine has been researched along with Osteoarthritis, Knee in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bai, X; Cai, D; Fang, H; Liu, X; Ouyang, J; Pan, J; Sun, Q; Wang, H; Xie, D; Yan, B; Yang, J; Zeng, C; Zhang, H; Zhang, T; Zhao, C1

Other Studies

1 other study(ies) available for 4-phenylbutylamine and Osteoarthritis, Knee

ArticleYear
mTORC1 activation downregulates FGFR3 and PTH/PTHrP receptor in articular chondrocytes to initiate osteoarthritis.
    Osteoarthritis and cartilage, 2017, Volume: 25, Issue:6

    Topics: Adult; Aged; Animals; Butylamines; Cartilage, Articular; Cell Proliferation; Chondrocytes; Down-Regulation; Female; Humans; Hypertrophy; Immunosuppressive Agents; Knee Joint; Male; Mechanistic Target of Rapamycin Complex 1; Menisci, Tibial; Mice; Mice, Knockout; Middle Aged; Osteoarthritis; Osteoarthritis, Knee; Receptor, Fibroblast Growth Factor, Type 3; Receptor, Parathyroid Hormone, Type 1; Reverse Transcriptase Polymerase Chain Reaction; Sirolimus; TOR Serine-Threonine Kinases; Tuberous Sclerosis Complex 1 Protein; Tumor Suppressor Proteins; Young Adult

2017